These changes occur in other cancers, e.g., FH- and SDH-deficient renal cell carcinomas, where biallelic deletion of the target enzyme leads to extreme accumulation of the upstream metabolites fumarate and succinate, respectively (17). The gene discussed is SDHB; the disease is cancer.